capability
Strategy & techno-economic consulting
TEA, scale-up, M&A, IP valuation, market entry, value-chain analysis.
Where it's used
Biotech IP valuation
Consultancies and data platforms that value biotechnology and pharmaceutical patent portfolios for licensing negotiations, M&A, litigation and capital raises — translating a patent estate covering therapeutics, diagnostics or platform technologies into a defensible monetary figure.
Techno-economic analysis (TEA) for bioprocesses
Advanced process simulation and financial modeling services that determine the commercial viability, optimal facility sizing, and Cost of Goods Sold (COGS) for emerging biomanufacturing technologies before capital is deployed.